Compared to Estimates, Inspire (INSP) Q2 Earnings: A Look at Key Metrics
For the quarter ended June 2023, Inspire Medical Systems (INSP) reported revenue of $151.09 million, up 65.3% over the same period last year. EPS came in at -$0.41, compared to -$0.53 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $137.66 million, representing a surprise of +9.76%. The company delivered an EPS surprise of +19.61%, with the consensus EPS estimate being -$0.51.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Inspire performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Total U.S. Medical Centers: 1045 compared to the 1026.5 average estimate based on two analysts.
New U.S. Medical Centers: 72 compared to the 53.5 average estimate based on two analysts.
Geographic Revenue- United States: $144.75 million compared to the $133.22 million average estimate based on five analysts.
Geographic Revenue- All other countries: $6.34 million versus the five-analyst average estimate of $3.77 million.
View all Key Company Metrics for Inspire here>>>
Shares of Inspire have returned -9.9% over the past month versus the Zacks S&P 500 composite's +3.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Inspire Medical Systems, Inc. (INSP) : Free Stock Analysis Report
